To discover whether JNK and p38 operated independently (but the timing of activation differed) or whether JNK caused downstream p38 activation, we treated RCC cells with mCD40L in the presence of JNK or p38 inhibitor and p-JNK and p-p38 expression was assessed. Here, MAPK8 is linked to renal cell carcinoma.